Blog

May 28, 2020  |  By Carla Nieser

Chimeron Bio and George Mason University’s National Center for Biodefense and Infectious Diseases Partner to Develop a Coronavirus (COVID-19) Vaccine using ChaESAR™ Technology

3 Minute Read

Read More

April 16, 2020  |  By Carla Nieser

Chimeron Bio Appoints Eminent Virologist Dr. Jonathan Smith to its Scientific Advisory Board as it Initiates COVID-19 Vaccine Program

1 Minute Read

Read More

April 2, 2020  |  By Carla Nieser

A Message from the CEO on the COVID-19 Initiative

8 Second Read

Read More

February 12, 2020  |  By Carla Nieser

Chimeron Bio Announces Appointment of Dr. Dominique Gouty to its Scientific Advisory Board

1 Minute Read

Read More

Harnessing the Power of saRNA with ChaESAR

Chimeron Bio’s ChaESAR platform is enabling application of saRNA biology to treat multiple genetic disorders and diseases.

See How